Weighted Average Number of Shares Outstanding, Diluted of NEUROONE MEDICAL TECHNOLOGIES Corp from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 50,331,155, a 63% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 40,152,873, a 50% increase from 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 26,762,392, a 48% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 18,121,108, a 13% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 50,331,155 +19,450,740 +63% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 40,152,873 +13,390,481 +50% 01 Jul 2025 30 Sep 2025 10-K 17 Dec 2025 2025 FY
Q2 2025 48,604,996 +21,252,336 +78% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 31,111,786 +5,201,308 +20% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 30,880,415 +6,884,805 +29% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q1
Q3 2024 26,762,392 +8,641,284 +48% 01 Jul 2024 30 Sep 2024 10-K 17 Dec 2025 2025 FY
Q2 2024 27,352,660 +9,773,789 +56% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q3
Q1 2024 25,910,478 +9,495,683 +58% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q2
Q4 2023 23,995,610 +7,764,613 +48% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q1
Q3 2023 18,121,108 +2,122,541 +13% 01 Jul 2023 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 17,578,871 +1,385,429 +8.6% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q3
Q1 2023 16,414,795 +224,928 +1.4% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 16,230,997 +822,517 +5.3% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q1
Q3 2022 15,998,567 01 Jul 2022 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q2 2022 16,193,442 +4,234,341 +35% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q3
Q1 2022 16,189,867 +4,951,783 +44% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q2
Q4 2021 15,408,480 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2023 Q1
Q2 2021 11,959,101 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q3
Q1 2021 11,238,084 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q2 2011 4,500,000 +333,333 +8% 01 Apr 2011 30 Jun 2011 10-Q/A 06 Sep 2011 2011 Q2
Q2 2010 4,166,667 01 Apr 2010 30 Jun 2010 10-Q/A 06 Sep 2011 2011 Q2

NEUROONE MEDICAL TECHNOLOGIES Corp Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 40,152,873 +13,390,481 +50% 01 Oct 2024 30 Sep 2025 10-K 17 Dec 2025 2025 FY
2024 26,762,392 +8,641,284 +48% 01 Oct 2023 30 Sep 2024 10-K 17 Dec 2025 2025 FY
2023 18,121,108 +2,122,541 +13% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 15,998,567 +5,301,768 +50% 01 Oct 2021 30 Sep 2022 10-K 15 Dec 2023 2023 FY
2021 10,696,799 01 Oct 2020 30 Sep 2021 10-K 22 Dec 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.